Metoprolol Tartrate Injection, Solution
Product Images NDC 0409-2016

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Metoprolol Tartrate (NDC 0409-2016). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Metoprolol 01)

Chemical structure of Metoprolol Tartrate showing the molecular arrangement of the metoprolol moiety combined with the tartaric acid component.*

FDA Label Image

Logo (Metoprolol 02)

FDA Label Image

Principal Display Panel (5 mL Vial Label)

Metoprolol Tartrate Injection, USP 5 mg/5 mL (1 mg/mL) single-dose vial label for intravenous use. The label includes storage instructions at 20 to 25°C and protection from light. Distributed by Hospira, Inc., Lake Forest, IL, USA.*

FDA Label Image

Principal Display Panel (5 mL Vial Carton)

Metoprolol Tartrate Injection, USP 5 mg/5 mL (1 mg/mL) intravenous solution packaging label. The carton contains ten 5 mL single-dose fliptop vials. Labeler is Hospira, Inc. The label includes dosage strength, usage route, storage instructions, and NDC codes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.